|
Restenosis
Citations 101-110 of 538 total displayed.
|
Past content
(since Jan 1999):
|
- Vascular Medicine
Leukocyte Engagement of Platelet Glycoprotein Ib via the Integrin Mac-1 Is Critical for the Biological Response to Vascular Injury
- Yunmei Wang, Masashi Sakuma, Zhiping Chen, Valentin Ustinov, Can Shi, Kevin Croce, Alexandre C. Zago, Jose Lopez, Patrick Andre, Edward Plow, and Daniel I. Simon
Circulation 2005;112:2993-3000; published online before print as doi:10.1161/CIRCULATIONAHA.105.571315
[Abstract]
[Full text]
- Editorials
Prevention of Restenosis by Systemic Drug Therapy: Back to the Future?
- Albert Schömig, Adnan Kastrati, and Rainer Wessely
Circulation 2005;112:2759-2761, doi:10.1161/CIRCULATIONAHA.105.583484
[Full text]
- Coronary Heart Disease
Pioglitazone Reduces Neointima Volume After Coronary Stent Implantation: A Randomized, Placebo-Controlled, Double-Blind Trial in Nondiabetic Patients
- Nikolaus Marx, Jochen Wöhrle, Thorsten Nusser, Daniel Walcher, Angelika Rinker, Vinzenz Hombach, Wolfgang Koenig, and Martin Höher
Circulation 2005;112:2792-2798; published online before print as doi:10.1161/CIRCULATIONAHA.105.535484
[Abstract]
[Full text]
- Interventional Cardiology
Coronary Stent Restenosis in Patients Treated With Cilostazol
- John S. Douglas, Jr, David R. Holmes, Jr, Dean J. Kereiakes, Cindy L. Grines, Elizabeth Block, Ziyad M.B. Ghazzal, Douglas C. Morris, Henry Liberman, Karen Parker, Claudine Jurkovitz, Nancy Murrah, Jovonne Foster, Pamela Hyde, G.B. John Mancini, William S. Weintraub for the Cilostazol for Restenosis Trial (CREST) Investigators
Circulation 2005;112:2826-2832; published online before print as doi:10.1161/CIRCULATIONAHA.104.530097
[Abstract]
[Full text]
- Interventional Cardiology
Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized Trials
- Laura Mauri, E. John Orav, Susana C. Candia, Donald E. Cutlip, and Richard E. Kuntz
Circulation 2005;112:2833-2839, doi:10.1161/CIRCULATIONAHA105.570093
[Abstract]
[Full text]
- Articles
Leukocyte Engagement of Platelet Glycoprotein Ib via the Integrin Mac-1 Is Critical for the Biological Response to Vascular Injury
- Yunmei Wang, Masashi Sakuma, Zhiping Chen, Valentin Ustinov, Can Shi, Kevin Croce, Alexandre C. Zago, Jose Lopez, Patrick Andre, Edward Plow, and Daniel I. Simon
Circulation published October 31, 2005, doi:10.1161/CIRCULATIONAHA.105.571315
[Abstract]
- Articles
Pioglitazone Reduces Neointima Volume After Coronary Stent Implantation. A Randomized, Placebo-Controlled, Double-Blind Trial in Nondiabetic Patients
- Nikolaus Marx, Jochen Wöhrle, Thorsten Nusser, Daniel Walcher, Angelika Rinker, Vinzenz Hombach, Wolfgang Koenig, and Martin Höher
Circulation published October 24, 2005, doi:10.1161/CIRCULATIONAHA.105.535484
[Abstract]
- Articles
Coronary Stent Restenosis in Patients Treated With Cilostazol
- John S. Douglas, Jr, David R. Holmes, Jr, Dean J. Kereiakes, Cindy L. Grines, Elizabeth Block, Ziyad M.B. Ghazzal, Douglas C. Morris, Henry Liberman, Karen Parker, Claudine Jurkovitz, Nancy Murrah, Jovonne Foster, Pamela Hyde, G. B. John Mancini, William S. Weintraub for the Cilostazol for Restenosis Trial (CREST) Investigators
Circulation published October 24, 2005, doi:10.1161/CIRCULATIONAHA.104.530097
[Abstract]
- Editorials
Genomics of In-Stent Restenosis: Early Insights Into a Complex Disease
- Santhi K. Ganesh and Elizabeth G. Nabel
Circulation 2005;112:2378-2379, doi:10.1161/CIRCULATIONAHA.105.574780
[Full text]
- Genetics
Genetic Inflammatory Factors Predict Restenosis After Percutaneous Coronary Interventions
- Pascalle S. Monraats, Nuno M.M. Pires, Willem R.P. Agema, Aeilko H. Zwinderman, Abbey Schepers, Moniek P.M. de Maat, Pieter A. Doevendans, Robbert J. de Winter, René A. Tio, Johannes Waltenberger, Rune R. Frants, Paul H.A. Quax, Bart J.M. van Vlijmen, Douwe E. Atsma, Arnoud van der Laarse, Ernst E. van der Wall, and J. Wouter Jukema
Circulation 2005;112:2417-2425, doi:10.1161/CIRCULATIONAHA.105.536268
[Abstract]
[Full text]
|
|
